SCHEMBL4425859

SCHEMBL4425859

CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.80
NR1I2 O75469 2/20 0.80
PTGS2 P35354 2/20 0.80
PGR P06401 1/20 0.80
PDE4D Q08499 1/20 0.80
ALDH1A1 P00352 9/20 0.75
CYP3A4 P08684 2/20 0.75
ALOX15 P16050 2/20 0.75
HSD17B10 Q99714 2/20 0.75
TDP1 Q9NUW8 2/20 0.75
TSHR P16473 1/20 0.75
CYP19A1 P11511 4/20 0.60
MAPT P10636 4/20 0.60
PPARG P37231 3/20 0.60
OXER1 Q8TDS5 3/20 0.60
RXRA P19793 2/20 0.60
FFAR1 O14842 2/20 0.60
F7 P08709 3/20 0.52
F3 P13726 3/20 0.52
PTGS1 P23219 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL442556 1.00 ADORA3 (0.80) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL4984694 1.00 ADORA3 (0.80) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL15130626 1.00 ADORA3 (0.80) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL4984691 1.00 ADORA3 (0.80) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL16994601 0.94 ADORA3 (0.70) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL11467652 0.94 ADORA3 (0.70) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL11467654 0.94 ADORA3 (0.70) ADORA3NR1I2PTGS2PGRPDE4D
Icosapent Ethyl SCHEMBL29356075 0.93 ADORA3 (0.93) ADORA3NR1I2PTGS2PGRPDE4D
SCHEMBL21734038 0.92 ADORA3 (0.69) ADORA3NR1I2PTGS2PGRPDE4D
Icosapent Ethyl SCHEMBL119168 0.89 ADORA3 (1.00) ADORA3NR1I2PTGS2PGRPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4475828-A1 METHODS FOR MONITORING PATIENT RESPONSE TO TREATMENT OF RETINAL OXIDATIVE DISEASES Biojiva LLC (US) 2024-12-18 EP disclosed
US-20230333087-A1 METHODS FOR MONITORING PATIENT RESPONSE TO TREATMENT OF RETINAL OXIDATIVE DISEASES BIOJIVA LLC (US) 2023-10-19 US disclosed
WO-2023154484-A1 METHODS FOR MONITORING PATIENT RESPONSE TO TREATMENT OF RETINAL OXIDATIVE DISEASES RETROTOPE, INC. (US) 2023-08-17 WO disclosed
US-9381213-B2 Antiviral and immune stimulant pharmaceutical composition SINNEX MUSZAKI FEJLESZTO ES TANACSADO KFT (HU) 2016-07-05 US disclosed
CN-101068540-B Antiviral and immunostimulating marine fish oil composition SINNEX MUESZAKI FEJLESZTOE S T 2013-01-09 CN disclosed
EP-1830861-B1 ANTIVIRAL AND IMMUNOSTIMULATING MARINE FISH OIL COMPOSITION SINNEX MUESZAKI FEJLESZTOE ES (HU) 2009-04-22 EP disclosed
US-20080131519-A1 Novel Antiviral and Immune Stimulant Pharmaceutical Composition SINNEX MUSZAKI FEJILESZTO ES TANACSADO KFT (HU) 2008-06-05 US disclosed
US-7365219-B2 Solid phase extraction method for obtaining high-purity unsaturated compounds or derivatives of said compounds NUTRINOVA NUTRITION SPECIALTIES & FOOD INDREDIENTS GMBH (DE) 2008-04-29 US disclosed
EP-1830861-A2 ANTIVIRAL AND IMMUNOSTIMULATING MARINE FISH OIL COMPOSITION Sinnex Müszaki Fejlesztö S Tanacsado KFT (HU) 2007-09-12 EP disclosed
WO-2006059169-A2 ANTIVIRAL AND IMMUNOSTIMULATING MARINE FISH OIL COMPOSITION SINNEX MÜSZAKI FEJLESZTÖ ÉS TANÁCSADÓ KFT (HU) 2006-06-08 WO disclosed
US-20040162437-A1 Solid phase extraction method for obtaining high-purity unsaturated compounds or derivatives of said compounds NUTRINOVA NUTRITION SPECIALIST & FOOD INGREDIENTS GMBH (DE) 2004-08-19 US disclosed
US-20020095007-A1 Lewis acid-catalyzed polymerization of biological oils and resulting polymeric materials IOWA STATE UNIVERSITY RESEARCH FOUNDATION 2002-07-18 US disclosed
US-5034414-A Nutrients in emulsions for transfusions containing unsaturated acids and esters TERUMO KABUSHIKI KAISHA (JP) 1991-07-23 US disclosed